Benign Prostatic Hyperplasia Therapeutics Market by Therapeutic Class (Alpha Blocker, 5- Alpha Reductase Inhibitor, Phosphodiesterase-5 Inhibitor, and Others), and Therapy (Mono Drug Therapy and Combination Drug Therapy) - Global Opportunity Analysis and Industry Forecast, 2018-2025

Market: Pharmaceuticals

, 205 pages report, published by Allied Market Research

Report ThumbnailJuly-2018
The prostate is a walnut-sized gland that surrounds the urethra in the male reproductive system. The main function of this gland is to secrete a fluid, which mixes with the fluids from other glands and sperm cells from the testicles to generate semen. Benign prostatic hyperplasia (BPH) is a non-malignant increase in the size of the prostate gland. This increase blocks the urine flow from the bladder, which results in increased urination frequency at night, urinary hesitancy, and urinary retentio

Read More
  • FIGURE 01. BENIGN PROSTATIC HYPERPLASIA THERAPEUTICS MARKET SEGMENTATION
  • FIGURE 02. TOP INVESTMENT POCKETS
  • FIGURE 03. TOP PLAYER POSITIONING, 2017
  • FIGURE 04. BARGANING POWER OF BUYERS
  • FIGURE 05. BARGANING POWER OF SUPPLIERS
  • FIGURE 06. THREAT OF SUBSTITUTION
  • FIGURE 07. THREAT OF NEW ENTRANT
  • FIGURE 08. COMPETITIVE RIVALRY
  • FIGURE 09. IMPACT ANALYSES
  • FIGURE 10. CLINICAL TRIALS IN BENIGN PROSTATIC HYPERPLASIA THERAPEUTICS MARKET, BY REGION
  • FIGURE 11. CLINICAL TRIALS IN BPH THERAPEUTICS MARKET, NORTH
Read More
  • TABLE 01. GLOBAL BENIGN PROSTATIC HYPERPLASIA THERAPEUTICS MARKET, BY THERAPEUTIC CLASS, 2017-2025 ($MILLION)
  • TABLE 02. GLOBAL ALPHA BLOCKERS MARKET, BY REGION, 2017-2025 ($MILLION)
  • TABLE 03. GLOBAL 5-ALPHA REDUCTASE INHIBITORS MARKET, BY REGION, 2017-2025 ($MILLION)
  • TABLE 04. GLOBAL PHOSPHODIESTERASE 5 INHIBITOR MARKET, BY REGION, 2017-2025 ($MILLION)
  • TABLE 05. GLOBAL OTHER BENIGN PROSTATIC HYPERPLASIA THERAPEUTICS MARKET, BY REGION, 2017-2025 ($MILLION)
  • TABLE 06. GLOBAL BENIGN PROSTATIC HYPERP
Read More
  • CHAPTER 1: INTRODUCTION
  • 1.1. Report description
  • 1.2. Key benefits for stakeholders
  • 1.3. Key market segments
  • 1.3.1. List of key players profiled in the report
  • 1.4. Research methodology
  • 1.4.1. Secondary research
  • 1.4.2. Primary research
  • 1.4.3. Analyst tools and models
  • CHAPTER 2: EXECUTIVE SUMMARY
  • 2.1. Key findings of the study
  • 2.2. CXO perspective
  • CHAPTER 3: MARKET OVERVIEW
  • 3.1. Market definition and scope
  • 3.2. Key findings
  • 3.2.1. Top investment pockets
  • 3.3. Top player positioning, 2017
  • 3
Read More
  • According to a new report published by Allied Market Research, titled, Benign Prostatic Hyperplasia Therapeutics Market, by Therapeutics Class and Therapy: Global Opportunity Analysis and Industry Forecast, 2018-2025," the market was valued at $10,689 million in 2017, and is projected to reach $20,097 million in 2025, registering a CAGR of 8.1% from 2018 to 2025.

    Benign prostatic hyperplasia (BPH) is a medical condition in which a males prostate gland size increases abnormally. This condition r
Read More

Related Products

Report LogoAugust-2018

PEGylated Protein Therapeutics Market by Product Type (Colony Stimulating Factor, Interferon, Erythropoietin (EPO), Recombinant Factor VIII, Monoclonal Antibody, Enzyme, and Others) By Application (Cancer, Autoimmune Disease, Hepatitis, Multiple Sclerosis, Hemophilia, Gastrointestinal Disorder, and Others) By Sales Channel (Hospital Pharmacy, Online Provider, and Retail Pharmacy) - Global Opportunity Analysis and Industry Forecast, 2018-2025

From USD 0
  • Pharmaceuticals
  • Industry Report
  • 166Pages
Allied Market ResearchBenign Prostatic Hyperplasia Therapeutics Market by Therapeutic Class (Alpha Blocker, 5- Alpha Reductase Inhibitor, Phosphodiesterase-5 Inhibitor, and Others), and Therapy (Mono Drug Therapy and Combination Drug Therapy) - Global Opportunity Analysis and Industry Forecast, 2018-2025 Product ThumbnailBenign Prostatic Hyperplasia Therapeutics Market by Therapeutic Class (Alpha Blocker, 5- Alpha Reductase Inhibitor, Phosphodiesterase-5 Inhibitor, and Others), and Therapy (Mono Drug Therapy and Combination Drug Therapy) - Global Opportunity Analysis and Industry Forecast, 2018-2025 , Industry ReportProduct #: 1186103
GlobalData
TeleResearch
Global Markets Direct
GBI Research
MarketsandMarkets
MicroMarketMonitor
PayPal Acceptance Mark
SSL Certificate
Copyright © 2020 Global Market Analyst. All Rights Reserved